Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

GLP-1 improves neuropathology after murine cold lesion brain trauma

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Comment on "A second trigeminal CGRP receptor: function and expression of the AMY1 receptor"

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

  2. A second trigeminal CGRP receptor: function and expression of the AMY1 receptor

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Sulfatide levels correlate with severity of neuropathy in metachromatic leukodystrophy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Pituitary adenylate cyclase activating polypeptide and migraine

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Reduced ceramide synthase 2 activity causes progressive myoclonic epilepsy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Antibiotic prescribing in paediatric inpatients in Ghana: a multi-centre point prevalence survey

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Population Pharmacokinetics of the Antimalarial Amodiaquine: a Pooled Analysis To Optimize Dosing

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Traffic flow and microbial air contamination in operating rooms at a major teaching hospital in Ghana

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Detection of Glycan Shedding in the Blood: New Class of Multiple Sclerosis Biomarkers?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

OBJECTIVES: In this study, we address a gap in knowledge regarding the therapeutic potential of acute treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist after severe brain trauma. Moreover, it remains still unknown whether GLP-1 treatment activates the protective, anti-neurodegenerative cAMP response element binding protein (CREB) pathway in the brain in vivo, and whether activation leads to observable increases in protective, anti-neurodegenerative proteins. Finally, we report the first use of a highly sensitive in vivo imaging agent to assess reactive species generation after brain trauma.

METHODS: Severe trauma was induced with a stereotactic cryo-lesion in mice and thereafter treated with vehicle, liraglutide, or liraglutide + GLP-1 receptor antagonist. A therapeutic window was established and lesion size post-trauma was determined. Reactive oxygen species were visualized in vivo and quantified directly ex vivo. Hematological analysis was performed over time. Necrotic and apoptotic tone and neuroinflammation was assessed over time. CREB activation and CREB-regulated cytoprotective proteins were assessed over time.

RESULTS: Lira treatment reduced lesion size by ∼50% through the GLP-1 receptor. Reactive species generation was reduced by ∼40-60%. Necrotic and apoptotic tone maintained similar to sham in diseased animals with Lira treatment. Phosphorylation of CREB was markedly increased by Lira in a GLP-1 receptor-dependent manner. CREB-regulated cytoprotective and anti-neurodegenerative proteins increased with Lira-driven CREB activation.

INTERPRETATION: These results show that Lira has potent effects after experimental trauma in mice and thus should be considered a candidate for critical care intervention post-injury. Moreover, activation of CREB in the brain by Lira - described for the first time to be dependent on pathology - should be investigated further as a potential mechanism of action in neurodegenerative disorders.

OriginalsprogEngelsk
TidsskriftAnnals of Clinical and Translational Neurology
Vol/bind1
Udgave nummer9
Sider (fra-til)721-32
Antal sider12
DOI
StatusUdgivet - sep. 2014

ID: 44829054